Marvell shares slip after analysts lift targets on guidance
Marvell shares were down 1.7% to $282.19 as multiple analysts raised price targets following investor-day growth guidance.
By George Glover Marvell Technology is getting a ton of praise on Wall Street -- but perhaps that's only natural for a company that said it expects revenue to surge by 55% to 60% a year for the next half-decade. At least 18 analysts have raised their price targets so far this week, according to FactSet data. That came after the chip and networking company set ambitious growth targets at an investor day in New York. One of those bulls is StoneX's Cody Acree, who raised his price target to $375 from $275 late Tuesday.
The investor day "reset both the size and duration of Marvell's AI opportunity," he wrote in a research note. Acree rates the stock Buy. His new price target implies shares can rally 31% from their level as of Tuesday's close. "Tone was unequivocally bullish, topping expectation, as management materially raised financial targets," Oppenheimer analyst Rick Schafer said on Wednesday as he hiked his own price target to $425 from $325.
Schafer rates Marvell at Outperform. The catalyst for the price-target hikes was Marvell's stellar guidance. The company forecast adjusted earnings of more than $30 a share and revenue of $70 billion to $90 billion in fiscal 2031. 2 billion.
8% on Tuesday, rallying as soon as CEO Matt Murphy unveiled the revenue target. They're up 238% in 2026, soaring thanks to the AI boom driving up demand for chips and networking products. com This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires October 07, 2026 08:19 ET (12:19 GMT) Copyright (c) 2026 Dow Jones & Company, Inc. The statements in this document shall not be considered as an objective or independent explanation of the matters. Please note that this document (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and (b) is not subject to any prohibition on dealing ahead of the dissemination or publication of investment research.